X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Three Viruses That Pharma Sector Needs To Gear Up Against

Content Team by Content Team
23rd August 2022
in News, Research & Development
Three Viruses That Pharma Sector Needs To Gear Up Against

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak of the Langya henipavirus in China also leaked. Researchers and public health officials are looking toward the future in an effort to predict what might trigger the next outbreak, even though COVID-19 is unlikely to be eradicated and the pandemic itself is not gone.

The main focus is on zoonotic viruses, including COVID-19’s causative agent, SARS-CoV-2. Zoonotic viruses start out in animals and then spread to humans through contact or mutation. Ebola, Zika, and West Nile viruses are a few examples. Around 10,000 viruses have the potential to infect people, according to a study published in April, and the majority are circulating stealthily in wild mammals. Cross-species viral transmission is more likely as a result of changing land use and climate.

All To Keep A Close Eye On: Coronaviruses, Filoviruses, And Flaviviruses

Three general categories of viruses are being closely examined by researchers. Coronaviruses come first. These include the SARS-CoV-2 virus as well as the SARS and MERS-causing viruses. The last two moved from animals to people, and SARS-CoV-2 most certainly did as well. Typically, coronaviruses in humans cause mild to severe upper respiratory tract illnesses, but as COVID-19, SARS, and MERS have shown, they are also capable of becoming fatal.

The second is Ebola, a virus in the filovirus family. Ebola, another zoonotic illness, is most likely spread by bats or monkeys to people. Hemorrhagic fevers are brought on by it, which can result in catastrophic internal bleeding. The Marburg virus is an additional member of this class.

The third is virus transmission by mosquitoes, particularly flaviviruses. These are additionally spread via ticks. They include ailments including yellow fever, dengue, and West Nile. Because they don’t travel from person to person, the possibility of a pandemic is reduced. They are only transferred by mosquitoes, and sadly, as the temperature rises, their range is expanding.

Previous Post

New Zealand Advances Alzheimers Drug Development Process

Next Post

Hanmi Reintroduces Liver Drug After Raising Bioavailability

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Hanmi Reintroduces Liver Drug After Raising Bioavailability

Hanmi Reintroduces Liver Drug After Raising Bioavailability

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In